BELMONT, Calif., Jan. 10, 2011 /PRNewswire/ -- Ventus Medical, Inc., a privately held, medical device company, today announced that management will present at the JP Morgan 29th Annual Healthcare Conference to be held January 10 -13, 2011, at the Westin St. Francis Hotel in San Francisco, CA.
(Logo: http://photos.prnewswire.com/prnh/20090409/SF96872LOGO)
On January 13th at 10 AM, Peter Wyles, President and CEO, will provide a corporate overview, including expansion plans and strategic objectives. “2011 is an expansion year for Ventus Medical. Making PROVENT® Sleep Apnea Therapy available through multiple distribution channels will help millions of people seeking an alternative treatment for their obstructive sleep apnea,” says Mr. Wyles. “In support of those expansion efforts, we’ve also just launched a new website, www.proventtherapy.com, which provides key information for prospective patients and physician prescribers.”
About Ventus Medical
Ventus Medical is a medical device company focused on improving the lives of patients with sleep-disordered breathing. Located in Belmont, California, Ventus Medical has developed and markets PROVENT Sleep Apnea Therapy, an innovative, clinically proven treatment for obstructive sleep apnea (OSA). PROVENT Therapy is a prescription device that is FDA cleared and indicated for the treatment of OSA. It is an easy to use and disposable treatment that is effective in the treatment of mild, moderate and severe OSA. The treatment utilizes nasal expiratory positive airway pressure and has been clinically shown to reduce sleep apnea.
SOURCE Ventus Medical, Inc.
